Hannah Jane Gissel Fraychineaud

Prof. Hannah Jane Gissel Fraychineaud

George Washington University Hospital, Washington D.C., USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2015 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
NMNathan S. Mauser
Nathan S. Mauser
JMJames D. Michelson
James D. Michelson
HFHannah Jane Gissel Fraychineaud
Hannah Jane Gissel Fraychineaud
CHCorey Henderson
Corey Henderson
CMCyril Mauffrey
Cyril Mauffrey

12 April 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MBMasoud Baikpour
Masoud Baikpour
ACAlex Carlos
Alex Carlos
RMRyan Morasse
Ryan Morasse
HFHannah Jane Gissel Fraychineaud
Hannah Jane Gissel Fraychineaud
VPVictor Perez-Gutierrez
Victor Perez-Gutierrez
VMVidya Menon
Vidya Menon
Predicting the mortality risk of patients with Coronavirus Disease 2019 (COVID-19) can be valuable in allocating limited medical resources in the setting of outbreaks. This study assessed the role of a chest X-ray (CXR) scoring system in a multivariable model in predicting the mortality of COVID-19 patients by performing a single-center, retrospective, observational study including consecutive patients admitted with a confirmed diagnosis of COVID-19 and an initial CXR. The CXR severity score was calculated by three radiologists with 12 to 15 years of experience in thoracic imaging, based on the extent of lung involvement and density of lung opacities. Logistic regression analysis was used to identify independent predictive factors for mortality to create a predictive model. A validation dataset was used to calculate its predictive value as the AUROC. A total of 628 patients (58.1% male) were included in this study. Age (p < 0.001), sepsis (p < 0.001), S/F ratio (p < 0.001), need for mechanical ventilation (p < 0.001), and the CXR severity score (p = 0.005) were found to be independent predictive factors for mortality. We used these variables to develop a predictive model with an AUROC of 0.926 (0.891, 0.962), which was significantly higher than that of the WHO COVID severity classification, 0.853 (0.798, 0.909) (one-tailed p-value = 0.028), showing that our model can accurately predict mortality of hospitalized COVID-19 patients.